feed,title,long_url,short_url
SeekingAlpha,Synchrony expects CFPB's late fee rule to reduce 2024 EPS by $0.15-$0.25,https://seekingalpha.com/news/4076150,
SeekingAlpha,Eyenovia falls despite FDA nod for pain therapy,https://seekingalpha.com/news/4076149,
